Loading...
XSHE300272
Market cap445mUSD
Jan 09, Last price  
5.78CNY
1D
-1.53%
1Q
-1.53%
Jan 2017
-31.78%
IPO
24.21%
Name

Canature Health Technology Group Co Ltd

Chart & Performance

D1W1MN
XSHE:300272 chart
P/E
24.66
P/S
1.95
EPS
0.23
Div Yield, %
2.39%
Shrs. gr., 5y
0.19%
Rev. gr., 5y
13.16%
Revenues
1.67b
+0.67%
80,606,61896,040,612124,941,633165,041,363207,070,109240,717,358311,205,792374,737,699456,841,411642,995,032707,501,599901,022,8211,052,525,4991,181,121,6361,511,487,4281,660,642,4471,671,699,376
Net income
132m
+43.09%
11,352,74912,218,92626,268,81436,481,46239,734,70749,801,80156,974,11664,236,55876,012,57090,249,61358,010,094348,011,245100,512,74026,417,590104,859,88392,561,924132,446,680
CFO
375m
+141.15%
21,552,07219,418,45625,957,67047,729,40638,261,39339,690,31847,844,41380,250,32680,417,95949,975,30940,016,37696,051,452114,397,474140,429,986186,767,653155,435,268374,830,410
Dividend
Sep 04, 20240.05 CNY/sh
Earnings
May 16, 2025

Profile

Canature Health Technology Co., Ltd. engages in the research, development, manufacture, production of residential water treatment products in China, the Middle East, Europe, rest of Asia, North America, and internationally. Its products include whole-house water purifiers and softeners, commercial purified water dispensers, membrane reverse osmosis water purifiers, multi-way control valves, and composite pressure vessels. The company was formerly known as Shanghai Canature Environmental Products Co., Ltd. and changed its name to Canature Health Technology Co., Ltd. in July 2018. Canature Health Technology Co., Ltd. was founded in 2001 and is headquartered in Shanghai, China.
IPO date
Nov 02, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,671,699
0.67%
1,660,642
9.87%
Cost of revenue
1,235,332
1,347,913
Unusual Expense (Income)
NOPBT
436,367
312,730
NOPBT Margin
26.10%
18.83%
Operating Taxes
5,328
14,847
Tax Rate
1.22%
4.75%
NOPAT
431,040
297,883
Net income
132,447
43.09%
92,562
-11.73%
Dividends
(78,155)
(56,717)
Dividend yield
2.19%
1.94%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
703,665
523,420
Long-term debt
261,027
167,038
Deferred revenue
24,509
18,773
Other long-term liabilities
143,889
137,104
Net debt
(825,303)
(332,062)
Cash flow
Cash from operating activities
374,830
155,435
CAPEX
(80,238)
Cash from investing activities
(349,674)
Cash from financing activities
430,288
30,983
FCF
569,935
262,378
Balance
Cash
894,883
413,099
Long term investments
895,111
609,421
Excess cash
1,706,410
939,488
Stockholders' equity
1,371,724
1,162,187
Invested Capital
1,093,127
918,732
ROIC
42.85%
32.64%
ROCE
17.16%
16.32%
EV
Common stock shares outstanding
575,855
561,705
Price
6.20
19.00%
5.21
-27.54%
Market cap
3,570,302
22.00%
2,926,482
-28.24%
EV
2,817,368
2,621,627
EBITDA
515,594
388,489
EV/EBITDA
5.46
6.75
Interest
32,583
16,845
Interest/NOPBT
7.47%
5.39%